← Back to patent-cliff list

CAS 624-28-2

2,5-dibromopyridine

Codes: PERAM-010, TEDI-009, BEBT-908-012, PRAD-008

Application context (from source-drug indications)

Tonic-clonic seizurePerampanel HydratePartial-onset seizurePerampanel HydrateEpilepsyPerampanel HydrateSeizurePerampanel HydrateSkin and skin structure infectionTedizolid PhosphateStaphylococcal infectionTedizolid PhosphateBacterial skin diseaseTedizolid PhosphateDiffuse large B-cell lymphomaIfupinostat Hydrochloride大B细胞淋巴瘤Ifupinostat HydrochloridePeripheral T-cell lymphomaIfupinostat HydrochlorideNon-small cell lung cancerIfupinostat HydrochlorideBreast cancerIfupinostat HydrochlorideMetastatic breast cancerIfupinostat HydrochlorideConstipationPradigastatI型高脂蛋白血症PradigastatHypertriglyceridaemiaPradigastatCoronary artery lesionPradigastatHepatitis CPradigastatNon-alcoholic steatohepatitisPradigastat

Source drugs (routes using this intermediate)

DrugTierExpiry
Perampanel HydrateTier C — Watch / trade2028
Tedizolid PhosphateTier C — Watch / trade2029
Ifupinostat HydrochlorideTier C — Watch / trade-
PradigastatTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.